Email signals / 41
#41
| id | 41 |
|---|---|
| source_id | — |
| gmail_thread_id | 19e84cf8e77a334d |
| gmail_message_id | 19e84cf8e77a334d |
| email_date | 2026-06-01T20:10:54+00:00 |
| email_subject | Google Alert - "sands capital" investment |
| email_sender | googlealerts-noreply@google.com |
| signal_type | acquisition |
| company_name_raw | Rallybio; Avenzo Therapeutics; Sands Capital |
| matched_company_id | 9840 |
| amount_usd | — |
| valuation_usd | — |
| investor_names | — |
| signal_summary | CORROBORATION reading of exit_event 29 (Rallybio/Avenzo merger) + edge 3817 (Sands participated in $215M private placement). Outlet: Busi... |
| source_url | https://www.businesswire.com |
| confidence | high |
| reviewed | true |
| applied_to_db | true |
| applied_at | 2026-07-25T03:22:40.783947+00:00 |
| created_at | 2026-06-04T00:07:15.893144+00:00 |
| tenant_id | 1 |
| alert_term | sands capital investment |
| channel | alert |
| entry_reason | — |
| first_publication_at | — |
| provenance_type | aggregation |
| independence_group | google.com |
| reading_id | 34 |
| item_ordinal | 0 |
| category_slug | — |
| category_confidence | — |
| category_note | — |
| company_host | — |